September - APNA
September - APNA
September - APNA
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
PROFESSIONAL ISSUES<br />
Member questions – continued<br />
• 01/07/2012: 23%<br />
• 01/07/2013: 24%<br />
• 01/07/2010: 25%<br />
You can contact the ANF for further advice on<br />
pay and conditions.<br />
I have a keen interest in Well Women’s Health<br />
and, more specifically, incontinence. I have been<br />
furthering my education in this field by completing<br />
the Benchmarque course in Continence<br />
Management and a Pauline Chiarelli Workshop.<br />
As a result, I feel confident in promoting,<br />
discussing and educating women on this health<br />
condition. The practice GPs refer women to me<br />
for consultation. The issue is what do we ‘bill’<br />
them to still be ‘legal’ How can we work it out<br />
so it is of benefit to everyone<br />
This is exactly the issue we have been arguing<br />
for in the restriction of the current MBS PN<br />
item numbers. The only way you can ‘bill’ for<br />
incontinence services is by including the GP in<br />
the consult so that he/she can bill through a<br />
normal GP consult or you can privately bill for<br />
this service — which is uncommon, but quite<br />
OK (frequently done in New Zealand).<br />
The intention of the new PN funding incentive<br />
coming in 2012 is to allow a flexible funding<br />
model through which nurses can provide a range<br />
of clinical services without having to involve GPs<br />
for the purpose of billing. There is a high degree<br />
of opposition to this model of funding from the<br />
GPs and there will be a lot of working out to do<br />
in its implementation.<br />
You must not get ‘legal’ and ‘billing’ confused.<br />
You are legally able to provide the care in which<br />
you have been trained and are competent to do.<br />
Whether it can be funded is a different matter —<br />
the ‘for and on behalf of’ type of language in the<br />
MBS is not a legal ruling for the GPs.<br />
As a PN, I can see a huge advantage in the removal<br />
of ‘task based’ item numbers. Unfortunately, the<br />
majority of GPs only see the bottom line. Our GPs<br />
have already starting talking about reducing<br />
nursing hours as this has also come at the same<br />
time as when they are getting significantly less<br />
income due to the changes in health assessment<br />
funding. Are larger practices going to be<br />
disadvantaged financially from the proposed<br />
changes<br />
Larger practices are potentially going be<br />
disadvantaged under the new proposal due to<br />
the capping at 5 EFT GPs. However, we will have<br />
the opportunity to argue for increasing the cap<br />
through the advisory group process and both the<br />
medical and nursing groups agree on this point.<br />
In addition there is a commitment that if the<br />
practice can demonstrate that it will be<br />
disadvantaged under the new system, it can be<br />
grandfathered into the scheme over three years.<br />
This would provide plenty of time to assess the<br />
operational benefits and disadvantages. GPs who<br />
currently receive a percentage of the PN item<br />
numbers as income (contractor or employee GPs)<br />
will have a reduction in income. However, if the<br />
overall income to the practice is increased, the<br />
practice can revisit their contracts with those GPs<br />
and amend these to ensure no loss of income.<br />
There will be grandfathering arrangements for<br />
the first three years of the program to ensure<br />
that practices are not adversely impacted by the<br />
restructure of the Practice Incentive Program<br />
practice nurse incentive and the MBS practice<br />
nurse items.<br />
alginate gel with enzymes that kill absorbed bacteria 1<br />
Advanced technology wound care with 3 clinical benefits<br />
• Moist wound environment • Continuous auto-debridement • Broad spectrum anti-bacterial activity 1<br />
Grade 2 leg skin tear treated with Flaminal ® Hydro 2<br />
Day 0 Day 30<br />
Day 68<br />
www.flaminalaustralia.com<br />
alginate gel with enzymes that<br />
kill absorbed bacteria 1<br />
[1] White R. ‘Flaminal: A novel approach to wound bioburden control’, Wounds UK 2006, 2 (3): 64–69. [2] Data on file at Flen Pharma. FD10019<br />
4<br />
Flen Pharma NV<br />
Aspen Pharmacare Australia Pty Limited<br />
Blauwesteenstraat 87, B-2550 Kontich, Belgium<br />
ABN 51 096 236 985<br />
www.flenpharma.com<br />
34–36 Chandos Street, St Leonards NSW 2065<br />
Primary Times <strong>September</strong> 2010 ® : Trademark of Flen Pharma Ph +61 2 8436 8300 ■ www.aspenpharma.com.au